The rare reason for massive lactic aciduria and mitochondrial disorders: combined oxidative phosphorylation deficiency type 23 (COXPD23)

Abstract

Mitochondrial respiratory chain dysfunction and impaired oxidative phosphorylation are rare but significant causes of mitochondrial diseases in children, presenting with diverse clinical features. Combined oxidative phosphorylation deficiency type 23 (COXPD23), an autosomal recessive disorder due to GTPBP3 gene mutations, typically manifests as lactic acidosis, hypertrophic cardiomyopathy, and encephalopathy. This case report describes a male infant born at 35 weeks gestation, who exhibited severe lactic aciduria and hypotonia but no cardiomyopathy, which is atypical for COXPD23. Genetic analysis revealed a novel homozygous missense variant in the GTPBP3 gene. Despite intensive metabolic and supportive treatments, the patientʼs condition worsened, leading to death on the 23rd day. This case emphasizes the need to consider mitochondrial cytopathies in neonates with persistent metabolic acidosis and hyperlactatemia and highlights the importance of early genetic screening for accurate diagnosis and management.

Keywords

Neonatal period - Neonatology - Mortality

Publikationsverlauf

Eingereicht: 12. Juni 2024

Angenommen nach Revision: 30. Oktober 2024

Artikel online veröffentlicht:
22. November 2024

• References

• 1 Craven L, Alston CL, Taylor RW. et al. Recent advances in mitochondrial disease. Annual review of genomics and human genetics 2017; 18: 257-275
• 2 Yan HM, Liu ZM, Cao B. et al. Novel mutations in the GTPBP3 gene for mitochondrial disease and characteristics of related phenotypic spectrum: The first three cases from China. Front Genet 2021; 12: 611226
• 3 Armengod ME, Meseguer S, Villarroya M. et al. Modification of the wobble uridine in bacterial and mitochondrial tRNAs reading NNA/NNG triplets of 2-codon boxes. RNA Biol 2014; 11: 1495-1507
• 4 Kopajtich R, Nicholls TJ, Rorbach J. et al. Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy. Am J Hum Genet 2014; 95: 708-720
• 5 Wang Y, He J, Dong F. et al. A novel mutation in GTPBP3 causes combined oxidative phosphorylation deficiency 23 by affecting pre-mRNA splicing. Heliyon 2024; 10: e27199
• 6 Zhang Q, Ouyang Q, Xiang J. et al. Pathogenicity analysis of a novel variant in GTPBP3 causing mitochondrial disease and systematic literature review. Genes (Basel) 2023; 14: 552
• 7 Richards S, Aziz N, Bale S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-424
• 8 Martinez-Zamora A, Meseguer S, Esteve JM. et al. Defective expression of the mitochondrial-tRNA modifying enzyme GTPBP3 triggers AMPK-mediated adaptive responses involving complex I assembly factors, uncoupling protein 2, and the mitochondrial pyruvate carrier. PloS One 2015; 10: e0144273
• 9 Nardecchia F, Carrozzo R, Innocenti A. et al. Biallelic variants in GTPBP3: New patients, phenotypic spectrum, and outcome. Ann Clin Transl Neurol 2024; 11: 819-825